{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-031098","form_type":"8-K","ticker":"GRDX","cik":"0001604191","company_name":"GridAI Technologies Corp.","filed_at":"2024-03-05T23:59:59+00:00","discovered_at":"2026-05-14T18:03:24.782577+00:00","generated_at":"2026-06-05T03:49:33.656669+00:00","sec_items":["1.01","3.02","7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"FWBI raises ~$4.0M gross in registered direct offering; issues warrants","bullets":["Gross proceeds ~$4.0M from sale of 525,625 shares (or equivalents) at $7.61/share; net ~$3.6M.","Concurrent private placement: warrants to purchase up to 525,625 shares at $7.48, 5-year term.","Roth Capital Partners acting as exclusive placement agent; closing expected March 6, 2024.","Net proceeds intended for working capital and general corporate purposes."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-031098","json":"https://secwatch.observer/filing/0001104659-24-031098.json","markdown":"https://secwatch.observer/filing/0001104659-24-031098.md","text":"https://secwatch.observer/filing/0001104659-24-031098.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1604191/000110465924031098/0001104659-24-031098-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1604191/000110465924031098/tm248020d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-05T03:49:33.656669+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"2b3261def2ee4a4b6f1705f326ee03a68087b14c","claim":"GridAI Technologies Corp. entered into Placement Agency Agreement with Roth Capital Partners, LLC (effective 2024-03-03).","evidence_excerpt":"On March 3, 2024, First Wave BioPharma, Inc. (the “Company”) entered into a placement agency agreement (the “Placement Agency Agreement”) with Roth Capital Partners, LLC (the “Placement Agent”) and a securities purchase agreement (the “Purchase Agreement”) with certain purchasers pursuant to which the Company agreed to sell, in a registered direct offering (the “Offering”), an aggregate of (i) 173,100 shares (the “Shares”) of common stock, par value $0.0001 per share (the “Common Stock”), of the Company, and (ii) pre-funded warrants (the “Pre-Funded Warrants”) to purchase up to an aggregate of 352,525 shares of Common Stock (the “Pre-Funded Warrant Shares”).","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1604191/000110465924031098/0001104659-24-031098-index.htm","confidence":0.95,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"underwriting"},{"label":"Counterparty","value":"Roth Capital Partners, LLC"},{"label":"Effective","value":"2024-03-03"}],"fact_type":"material_agreement"},{"claim_id":"9cee35d8507424ca81465c44254c29f6fc9103e4","claim":"GridAI Technologies Corp. entered into Purchase Agreement with certain purchasers (effective 2024-03-03).","evidence_excerpt":"On March 3, 2024, First Wave BioPharma, Inc. (the “Company”) entered into a placement agency agreement (the “Placement Agency Agreement”) with Roth Capital Partners, LLC (the “Placement Agent”) and a securities purchase agreement (the “Purchase Agreement”) with certain purchasers pursuant to which the Company agreed to sell, in a registered direct offering (the “Offering”), an aggregate of (i) 173,100 shares (the “Shares”) of common stock, par value $0.0001 per share (the “Common Stock”), of the Company, and (ii) pre-funded warrants (the “Pre-Funded Warrants”) to purchase up to an aggregate of 352,525 shares of Common Stock (the “Pre-Funded Warrant Shares”).","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1604191/000110465924031098/0001104659-24-031098-index.htm","confidence":0.95,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"equity purchase"},{"label":"Counterparty","value":"certain purchasers"},{"label":"Effective","value":"2024-03-03"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}